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The aim of this paper is to evaluate the relationship of salivary ammonium levels and the presence
of bacteria with rheumatoid arthritis (RA) clinical disease activity in a cross‐sectional study of
Mexican patients. From a periodontal and disease activity standpoint, 132 consecutive RA
patients fulfilling clinical criteria were evaluated. Ammonia levels (including peptidyl arginine
deiminase activity) were evaluated by colorimetric assay and the presence of Porphyromonas
gingivalis, Tannerella forsythia, and Prevotella intermedia was evaluated by polymerase chain reac-
tion (PCR) technique. After a multivariate analysis, adjusting for clinical and serological parame-
ters, a significant association was only observed between severe periodontitis and probing
depth with high RA disease activity. Additionally, in contrast to P. gingivalis, the presence of T. for-
sythia was significantly associated with high disease RA activity even after multivariable adjust-
ment analysis. There was also a significant increase in ammonium levels in the high RA activity
group and a significant correlation between salivary ammonia and RA disease activity but not
with autoantibody titers. Similarly, we observed a significant increase in the ammonium levels
derived from the cultures of P. gingivalis and T. forsythia, with respect to P. intermedia and S.
gordonii cultures, or even healthy donors. These results suggest that RA activity is associated with
severe periodontitis, high salivary ammonium levels and the presence of T. forsythia.
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Rheumatoid arthritis (RA) is a chronic autoimmune disease character-
ized by inflammation, structural damage, and loss of function of the
synovial joints. Its etiology is unknown but it is associated with
several factors (Smolen, Aletaha, & McInnes, 2016), and recent
studies suggest that one of those involved in RA development and dis-
ease activity could be severe periodontitis (PD); (Chen et al., 2013,
Konig, Paracha, Moni, Bingham, & Andrade, 2015, Leech & Bartold,
2015, Payne, Golub, Thiele, & Mikuls, 2015, Venkataraman & Almas,
2015). It is well established that oral microbiome disruption in gingival- - - - - - - - - - - - - - - - - - - - - - - - - - -
e Creative Commons Attribution Li
ntal Research published by John Wpockets leads to PD, an oral chronic disease characterized by inflam-
mation and destruction of dental support tissues. It is also known that
certain bacterial strains, such as Porphyromonas gingivalis, Tannerella
forsythia, and Prevotella intermedia, are associated with PD (Darveau,
2010, Mihai et al., 2015, Walker, 2004). In particular, P. gingivalis has
been associated with the development of RA, mostly by the character-
istic expression of a secreted‐form of peptidyl arginine deiminase
(PAD; P. gingivalis, PPAD), capable of citrullinating host proteins and
potentially favoring the development of autoantibodies. (Konig et al.,
2015, Scher & Abramson, 2011, Wegner et al., 2010). Although P.
gingivalis seems critical in explaining the potential effects of severe- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
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108 MARTÍNEZ‐RIVERA ET AL.PD in the development of RA, its association with the presence of the
bacteria or anti‐P. gingivalis/anti‐PPAD antibodies is not always evident
(Konig et al., 2015, Scher et al., 2012, Ziebolz et al., 2011). Moreover,
global periodontal microbiome studies done in patients with early‐
onset RA do not show a potential relationship with P. gingivalis, but
with other germs (Anaeroglobus geminatus) or species from the
Prevotella and Leptotrichia genus (Scher et al., 2012).
On the other hand, the levels of ammonium in saliva, among other
factors, depend on the passive diffusion of ammonium from the blood
to the salivary glands and from the metabolism of arginine and urea by
the oral bacteria. Because the enzymatic determination of ammonium
can be coupled with the citrulination activity by PAD, we wanted to
know whether it is possible to observe differences between patient
groups and bacterial cultures.
In addition, association studies between RA and PD have led to
heterogeneous results, probably because the variables have not been
similarly controlled or clinical outcomes have been different in each
case. Therefore, the objective of this study is to confirm the associa-
tion between RA inflammatory disease activity in a homogeneous pop-
ulation positive to anti‐cyclic citrullinated peptide (αCCP+) antibodies,
oral PAD activity, and the prevalence of previously incompletely eval-
uated bacterial strains, such as T. forsythia.2 | MATERIALS AND METHODS
2.1 | Population and samples
Consecutive patients were recruited at the rheumatology outpatient
clinic of the Hospital General de Cuernavaca in Morelos, Mexico,
between July 2014 and June 2015. The cross‐sectional study
protocol was reviewed and approved by the institutional (INSP)
and hospital ethics' committee. Signed informed consent was
obtained from all patients during recruitment. All patients received
combination treatment with disease‐modifying antirheumatic drugs,
mainly methotrexate and cloroquine and, in some cases, 10 mg or
less per day of prednisone. No patients were treated with biologics.
All patients included were seen consecutively and classified as hav-
ing RA per the American College of Rheumatology/European League
Against Rheumatism (ACR/EULAR) 2010 criteria (Aletaha et al.,
2010). Disease activity was measured using a three‐variable index
DAS28 (swollen and tender peripheral joints and the erythrocyte
sedimentation rate [ESR], DAS28‐ESR) and was performed by the
same rheumatologist (DXXF). Subsequently, the clinical activity index
used in this study DAS28‐ESR will be reported only as DAS28. For
the comparative analysis, patients were stratified per DAS28 activity
into the following groups: low disease activity (DAS28 remission to
3.2) and high disease activity (DAS28 > 3.2). All patients were αCCP
positive and had a complete medical history on file. Patients were
excluded if they had an uncontrolled systemic condition such as dia-
betes or hypertension or some other autoimmune disease, as well as
if they had been diagnosed with Sjögren's disease or sicca‐syndrome,
if they were active smokers and/or if they had received periodontal
treatment (antibiotics) in the year prior to the sampling or had
chronic liver disease. On the day of the clinical evaluation, patientsprovided venous blood and saliva samples; these were then proc-
essed on the same day and frozen at −80 °C.2.2 | Periodontal evaluation
As part of the clinical evaluation, RA patients were subject to peri-
odontal examination and testing. To determine the periodontal status,
the following parameters were recorded: probing depth, clinical degree
of tooth attachment, and bleeding upon probing. The periodontal sta-
tus in all patients was determined according to the criteria proposed
by the American Dental Association using a periodontal probe sug-
gested by the World Health Organization (Wiebe & Putnins, 2000)
and classified as follows: mild PD (colored area of the probe remains
completely visible at the deepest probing depth and supra or
subgingival calculus and/or defective margins are detected in at least
one sextant) and severe PD (colored area of the probe completely
disappears indicating a probing depth between 3.5 to 5.5 mm in at
least one sextant). Gingivorrhagia was determined as the presence of
spontaneous gum bleeding at probing. Dental mobility was determined
in the number of millimeters that teeth moved in alveolar bone and
dental loss was determined by the presence or absence of dental
organs. Cementum‐enamel junction was evaluated as previously
described (Eley & Cox, 1998). All periodontal evaluations were done
by the same person (JIMR).2.3 | Antibody determination
αCCP titers were determined using a commercial anti‐cyclic
citrullinated peptide enzyme‐linked immunosorbent assay (Euroimmun)
following the procedures recommended by manufacturer. Patients
were considered as αCCP positive if the titers were 5 RU/ml or
greater. Rheumatoid factor (RF) was qualitatively evaluated by nephe-
lometry. Relative abundance of circulating immunoglobulin G (IgG)
anti‐P. gingivalis antibodies were obtained by indirect enzyme‐linked
immunosorbent assay, using the whole bacterium (strain W83) as a
reference and anti‐Human IgG‐HRP for detection (Lee et al., 2015).2.4 | Enzymatic determination of salivary ammonium
levels
As a quantitative approximation of the contribution of bacterial PAD to
the oral microenvironment in patients with RA, we used a highly repro-
ducible enzymatic method, which is based on the determination of
ammonium levels either by the action of bacterial PAD or ammonium
already present in the saliva sample.
Total salivary ammonium levels were determined as follows: a
1.0 μg of saliva protein (determined by Bradford's technique) was
diluted in 50 μl of deionized water (Direct‐Q5UV‐R, MilliPore).
Samples were incubated in 150 μl tris‐base solution (200mM) pH 9,
8.5mM of α‐ketoglutaric acid (Sigma), 0.22mM of reduced
β‐Nicotinamide adenine dinucleotide (Sigma), and 3U of L‐Glutamic
Dehidrogenase (Sigma); a final volume of 200 μl was placed in 96 wells
(Corning UV plate). Additionally, 10 mM of benzoyl (Bz)‐L‐Arg‐ethyl‐
ester (BAEE, arginine rich substrate) was also included to the contribu-
tion of PAD activity. Ammonium levels were considered as referenced
MARTÍNEZ‐RIVERA ET AL. 109to the NADH oxidation, as described previously (Liao, Hsieh, Liu, &
Hung, 2005). Velocity was visualized at 340 nm in a spectrophotometer
(Epoch, Biotek) for 20 min with an interval of 2 min at 24 °C and deter-
mined using the following formula: Vel (mM/min/μg) = (ODi‐ODf/20)/ε
NADH(0.00622M)
Additionally, assays employing salivary samples from healthy
donors (n = 10) free from rheumatic and periodontal diseases were
employed as a reference of baseline ammonium salivary levels.
2.5 | Identification of oral bacteria
With the objective of evaluate if Tanerella forsythia could be associated
to RA or oral PAD activity, we compared its presence with respect
other bacteria species recognized as associated (Porphyromonas
gingivalis) and non‐associated (Prevotella intermedia) to RA develop-
ment (Mikuls et al., 2012, Wegner et al., 2010). All evaluations were
performed using end‐point PCR. Samples were obtained from
decanted saliva (~5 ml) in a 15‐ml sterile tube directly suspended in a
protease‐inhibitor (EASYpack, ROCHE). DNA was extracted by
TRIZOL (Invitrogen) as previously described (De La Garza‐Ramos,
Galan‐Wong, Caffesse, Gonzalez‐Salazar, & Pereyra‐Alferez, 2008).
Samples were stored at ‐75 °C. Specific bacterial 16S ribosome
primers were P. gingivalis forward, AAGGATTGTAAACTTCTTTTA
TAC; reverse, ACTGTTAGCAACTACCGATGT (Genebank POYRR16SC);
T. forsythia forward, GCGTATGTAACCTGCACCTGCCCGCA; reverse,
GAAGGCAGCTTACTAAGG (Genebank BFORR16S); P. intermedia for-
ward, GCATTTACCCTTCGAATAAGGACC; reverse, GAGTCAACATC
TCTGTATCCTGCG (Genebank PVORR16SD); PCR conditions were
denaturing 95 °C 30 cycles/5 min; annealing 55 °C/30 s; extending
72 °C/10 min, in a thermocycler (TECHNE3prime). PCR analysis was
performed using 2% agarose gel in TAE (tris‐acetate‐EDTA)/100mV/
10 min; densitometry was performed using a ChemiDoc XRP (Bio‐Rad)
transilluminator with Quantity One v.4.6.6 software. Presence of bac-
terial strains was considered positive if the density bands showed a
10‐fold intensity (INT*mm2) or greater with respect to gel background.
2.6 | Statistical analysis
Descriptive statistics were employed for continuous variables. Multi-
variate analysis was done adjusting for gender, age, time since onsetTABLE 1 Clinical and serological characteristic of RA patient groups
Low activity (DAS28 ≤ 3.2) n
Gender (Male/Female), n 1/35
Age, years, (SD) 46 (9.4)
Years since onset of RA, mean (SD) 3.0 (4.5)
DAS28, mean (SD) 2.2 (1.4)
αCCP, UR/mL 6.4 (17.4)
ESR, mm/h, mean (SD) 10.4 (2.8)
RF, n (% positive) 9 (25.0)
IgG anti‐P. gingivalis, AU (SD) 4.5 (3.2)
Note. αCCP = anti‐cyclic citrullinated peptide; ESR = erythrocyte sedimentation
*Mann–Whitney test, p < .05.
**Pearson chi2, p < .05%.of disease, RF, and ESR. Comparisons between groups were performed
using Mann–Whitney U testing, because experimental values did not
show a normal distribution. Kruskal–Wallis testing was performed to
compare patient and bacterial PAD activity. Spearman correlation test-
ing was employed to correlate PAD activity and DAS28. Statistical
significance was set at .05% (STATA v.13).3 | RESULTS
Initially, 208 RA patients were invited to participate in the study but
only 132 RA patients were positive to αCCP (αCCP+) and were
included in this analysis; of these, 129 were female. According to their
RA activity, patients were divided into two subgroups: 36 with low dis-
ease activity (DAS28 ≤ 3.2) and 96 with high disease activity
(DAS28 > 3.2, Table 1). We did not find statistical differences between
subgroups regarding gender, age, or time since onset of disease. Statis-
tically, significant differences between groups were found in αCCP
titers (p = .001), ESR (p < .001), and RF positivity (p < .01). No statistical
differences in anti‐P. gingivalis IgG‐antibody titers were observed
between groups.
A baseline association analysis (Table 2) between PD and RA
determined that severe PD (OR, 2.8 [1–16.8]), gingivorrhagia (OR,
2.7 [2.0–12.2]), dental mobility (OR, 2.1 [1.8–5.6]), and probing depth
(OR, 5.3 [1.6–7.1]) had a significantly higher OR in the highly active
RA patients. In an ulterior multivariable analysis, after adjusting for dif-
ferent parameters (age, time since onset of RA, ESR, and RF), only the
group of high RA activity showed an association to severe PD (OR, 3.3
(2.8–13.6), p < .004) and probing depth (OR, 4.8 (1.4–8.7), p < .009).
For their part, gingivorrhagia and dental mobility lost its high OR after
adjusting for ESR. Other periodontal parameters were not associated
with high RA activity either in the baseline analysis or after the adjust-
ment of parameters. Based on the sample size of the groups classified
in high and low DAS28, a statistical power of 98% was determined.
The lower half of Table 2 shows the association analysis between
the frequency of bacterial strains (P. gingivalis, T. forsythia, and
S. intermedia) and disease activity subgroups. In the baseline analysis,
a significant association was observed between high RA activity and
the presence of P. gingivalis (OR, 5.3 (1.8–6.1), p < .002) or the pres-
ence of T. forsythia (OR, 5.3 (1.4–6.3), p < .001). After statistical= 36 High activity (DAS28 > 3.2) n = 96 p
2/94
47.5 (11.1)
8.4 (7.8)
4.6 (0.9) .001**
139.9 (55.2) .001*
30.8 (1.3) .001*
93 (96.8) .01**
3.8 (0.72) .68*
rate; RA = rheumatoid arthritis; SD = standard deviation.
TABLE 2 Association analysis of periodontal characteristics between
RA patient subgroup
DAS28 vs p
Adjusteda OR
(95% IC) p
Severe periodontitis
Low activity 1.6 (0.8–3.4) .16 1.0 (1.0–1.1) .09
High activity 2.9 (2.0–9.3) .001* 3.3 (2.8–13.6) .004*
Gingivorrhagia
Low activity 1.7 (2.0–15.1) .09 1.1 (0.6–17.9) .09
High activity 2.7 (2.0–12.2) .003* 1.6 (0.9–2.9) .05
Dental mobility
Low activity 0.72 (0.9–5.7) .7 0.32 (0.015–9.4) .17
High activity 2.1 (1.8–5.6) .003* 1.5 (0.81–1.3) .07
Dental loss
Low activity 0.83 (0.25–2.6) .7 0.33 (0.3–2.4) .23
High activity 1.9 (0.55–6.5) .3 2.0 (0.4–4.9) .37
Probing depth
Low activity 0.53 (0.11–2.4) .45 0.46 (0.99–2.1) .32
High activity 5.3 (1.6–7.1) .005* 4.8 (1.4–8.7) .009*
CEJb
Low activity 0.85 (0.21–3.4) .83 0.97(0.21–4.3) .63
High activity 1.7 (1.01–5.6) .06 2.0 (0.15–5.9) .08
P. gingivalis
Low activity 1.6 (0.5–5.2) .42 1.7 (0.49–6.4) .37
High activity 5.3 (1.8–6.1) .002* 5.3 (4.8–5.9) .05
T. forsythia
Low activity 2.4 (0.7–8.0) .14 1.4 (0.9–1.9) .78
High activity 5.3 (1.4–6.3) .001* 4.4 (2.5–5.3) .002*
P. intermedia
Low activity 0.68 (0.16–2.7) .59 0.99 (0.96–1.0) .95
High activity 0.83 (0.26–2.6) .75 0.34 (0.07–1.6) .18
Note. ESR = erythrocyte sedimentation rate; RA = rheumatoid arthritis;
RF = rheumatoid factor.
aAdjusted by age, time since onset of RA, ESR, and RF.
bCementum‐enamel junction. Statistical analysis, chi2 Pearson.
*p < .05.
The use of bold in Table is to increasing visualization but in the actual
Table's format is not necessary to conserve the bold font.
FIGURE 1 Increased levels of total ammonium were observed in
salivary samples from high RA activity patients, in comparison to low
RA activity. Enzymatic assay for total ammonium levels determination
is described in Methods. Graphical analysis was done normalizing for
experimental control (without oral samples). Statistical comparison was
done employing Mann–Whitney test, considering p < .01 (**)
FIGURE 2 Total salivary ammonium levels positively correlated with
RA clinical activity. Values from all RA patient subgroups were
correlated (Spearman) with clinical activity (DAS28), showing ρ = 0.67
and p < .001
TABLE 3 Comparative total ammonium levelsa in culture media of
bacteria strains
P. gingivalis T. forsythia P. intermedia S. gordonni
m (SD) m (SD) m (SD) m (SD)
4.0 (0.06) 3.9 (0.02) 0.1 (0.17) 0.04 (0.23)
a[mM/μg]/control.
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remained only for T. forsythia (OR, 4.4 (2.5–5.3), p < .002). As before,
the baseline association between the high RA activity group and the
prevalence of P. gingivalis disappeared when adjusting for ESR. As
expected (Wegner et al., 2010), presence of P. intermedia did not
show an association with any RA disease activity group or baseline
data.
Comparing total ammonium levels in saliva samples of RA patients,
we found (Figure 1) significant differences between the low
(1.995 ± 0.48) and high (3.611 ± 0.76) RA disease activity groups
(p < .01%). We did not see statistical differences in saliva ammonium
levels between healthy donors and low RA activity patients
(Figure S1), whereas high activity patients showed a 180% increase
in ammonium levels. Because ammonium levels seemed to varybetween RA disease activity subgroups, a correlation analysis for all
RA patients was carried out. Figure 2 shows a significant correlation
(ρ = 0.67, p < .001) between total ammonium levels and DAS28, sug-
gesting a biological link between salivary environment and the RA dis-
ease activity. On the contrary, titers of aCCP antibodies showed no
statistical correlation with total ammonium levels in saliva samples
(data not shown).
TABLE 4 Total ammonium levelsa by soap culture of T. forsythia or T.f. + P.g
0.1 [μg/μl] m (SD) 0.5 [μg/μl] m (SD) 1.0 [μg/μl] m (SD) T. forsythia [1.0 μg/μl] + P. gingivalis [1.0 μg/μl] m (SD)
0.9 (0.15) 3.3 (0.13) 5.4 (0.37) 10.8 (0.32)
Note. P.g = Porphyromonas gingivalis; T.f = Tannerella forsythia; SD = standard deviation.
a[mM/μg]/control.
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enzymatic activity of PAD and ammonium already present in the saliva
sample, these results were compared with those obtained when using
individual cultures of the P. gingivalis, T forsythia, P. intermedia, and S.
gordonii strains (Table 3). The results showed that total ammonium
levels were practically undetectable in P. intermedia and S. gordonii,
but an increase of approximately 1,300% was observed when com-
pared with to P. gingivalis or T. forsythia cultures, suggesting that some
bacterial products characteristic of P. gingivalis or T. forsythia cultures
are responsible for the generation of high levels of ammonia in our
enzymatic assay.
Table 4 shows that this effect increases linearly with the increase
in protein concentration and has an additive character between the
cultures of both bacterial strains. This suggests that the presence of
at least these two bacteria contribute equally to alter either the level
of citrullination or the levels of ammonium in saliva, and these events
relate to the clinical activity of the patients with RA. On the other
hand, and in line with a higher prevalence of P. gingivalis or T. forsythia
in the subgroup with severe PD, we confirmed (Figure S2) that PAD
activity was significantly lower in the mild PD subgroup in comparison
to the severe subgroup (p < .001).4 | DISCUSSION
Several previous studies have suggested an association between
severe PD with RA; however, due to differences in the classification
of PD as well as the control of parameters, the results have been het-
erogeneous (Lee et al., 2015, Mikuls et al., 2014, Scher et al., 2012,
Seror et al., 2015, Ziebolz et al., 2011). In this respect, the lack of asso-
ciation between the prevalence of P. gingivalis or anti‐P. gingivalis anti-
bodies (e.g., in this study) with relation to RA raises important
questions about their participation in the autoimmune process (Scher
et al., 2012, Ziebolz et al., 2011). Furthermore, recent studies have sug-
gested that periodontal treatment alone can generate positive effects
in the clinical manifestations of RA patients (Biyikoglu et al., 2013,
Okada et al., 2013, Roman‐Torres et al., 2015); however, these studies
have been conducted with small numbers of patients and lack a rigor-
ous evaluation (Kaur, Bright, Proudman, & Bartold, 2014).
On the other hand, there is ample evidence that seems to coincide
with the fact that the oral microenvironment may cause periodontal
bacteria‐mediated chemical modification of connective tissue proteins,
present within the joints of RA patients (Venkataraman & Almas,
2015). In this regard, it has been confirmed that the peptidyl arginine
deiminase expressed by P. gingivalis (PPAD), despite having no homol-
ogy to the PADs present in mammals, leads to citrullination of human
proteins (Konig et al., 2015, Montgomery et al., 2016, Rodriguez, Stitt,
& Ash, 2009, Wegner et al., 2010). Furthermore, active participation ofPPAD was also confirmed in a collagen induced arthritis model, sug-
gesting a biological connection between P. gingivalis infection and RA
(Maresz et al., 2013). On the other hand, a comparative study with
10 other oral bacteria suggested that P. gingivalis was the only one
capable of carrying out this enzymatic reaction (Wegner et al., 2010);
however, T. forsythia was not included in this study. Additionally since
then, knowledge on the periodontal microbiology has been enriched
and compiled into the human oral microbiome (Cross, Faustoferri, &
Quivey, 2016); the genome of T. forsythia (Friedrich et al., 2015) in this
database has recently been corrected, allowing for the verification of
previous studies.
The present study confirms the existence of a significant associa-
tion between severe PD and probing depth with RA, as previous stud-
ies have done (Chou, Lai, Chen, Lin, & Chen, 2015, de Smit et al., 2012,
Fuggle, Smith, Kaul, & Sofat, 2016, Mikuls et al., 2014); however, no
association was observed with gum bleeding or tooth loss (although
an association was seen in the bivariate analysis, this was not observed
in the multivariate analysis, probably due to the sample size, and
should be explored further), as others have suggested (Demmer,
Molitor, Jacobs, & Michalowicz, 2011, Kobayashi et al., 2010,
Torkzaban, Hjiabadi, Basiri, & Poorolajal, 2012). Importantly, this asso-
ciation remained even after adjusting for clinical and serological param-
eters, suggesting an independent relationship between PD and RA. A
previous study within the same cohort, which evaluated the possible
clinical association of treatment response in RA patients with levels
of leptin or adiponectin, as well as overweight and obesity showed
an association of circulating leptin and clinical activity (Xibille‐
Friedmann et al., 2015), but that was not the case in the present study
because differences in the body mass index between patients did not
change the association values of PD or oral PAD activity (data not
shown). Similarly, pharmacological treatment appears to not have influ-
enced the results because more than 80% of patients remained within
the general treatment regimen (MTX + chloroquine + prednisone inci-
dentally). Also, no reports were found suggesting side effects of anti-
rheumatic treatment on the oral microenvironment.
For its part, it is important to note that the association of T. forsythia
with the high RA activity group remains even after adjusting for clinical
or serologic parameters (OR, 4.4 (2.5–5.3), p < .002), suggesting a poten-
tial role of the bacteria in the RA activity, similar to what was proposed
for P. gingivalis (Konig et al., 2015). On the other hand, and similarly to
other studies (Konig et al., 2011, Scher & Abramson, 2011, Ziebolz
et al., 2011), we did not observe a significant association between P.
gingivalis and high RA activity when performing the multivariate analy-
sis; in fact, after adjusting for ESR, the association observed in the bivar-
iate analysis was lost (Table 3). Finally, the presence of P. intermediawas
not associated at all with disease activity. It is well known that these
three bacteria commonly occur together in the sameperiodontal inflam-
matory process, and there is ample biological evidence that confirms
112 MARTÍNEZ‐RIVERA ET AL.their interrelationship (Endo et al., 2015, Ng et al., 2016, Zhu & Lee,
2016). In this sense, it is hard to understandwhyT. forsythiawas not pre-
viously compared with P. gingivalis (Wegner et al., 2010) based on PAD
type activity. All these results suggest that T. forsythia could express
proteins with a PAD‐type capacity and therefore participate with P.
gingivalis in establishing an oral microenvironment capable of
citrullination. This could provide a logical explanation for studies where
no association was observed between P. gingivalis and RA. In addition,
and perhapsmost importantly, these resultsmay explain the differences
between PAD activity and that dependent on the enzyme expressed by
P. gingivalis (PPAD; Laugisch et al., 2016). In agreement with this, a
recent study found that PAD activity in RA patients was increased in
comparison to PPAD activity (Laugisch et al., 2016), suggesting other
periodontal bacteria could participate in host protein citrullination.
Of note, this study has also shown a strong correlation between
total ammonium levels in saliva and clinical RA activity. Although ini-
tially it was proposed that the enzymatic assays allowed for the evalu-
ation of bacterial PAD activity, it is now evident that this technique
does not distinguish if the ammonium is already present in the saliva
sample, considering that the levels of ammonium in saliva depend,
among other factors, on the blood ammonium content and the metab-
olism of urea and arginine by the oral microbiome (Adeva, Souto,
Blanco, & Donapetry, 2012, Huizenga, Vissink, Kuipers, & Gips, 1999).
In the present study, the patients were not selected but correspond to
patients who attended the rheumatology clinic regularly and consecu-
tively. Also, saliva samples were collected, stored, and analyzed under
the same circumstances, so it could be suggested that the variations
of total ammonium observed in the results depends fundamentally on
the microbacterial component present in the patients. In that sense,
the enriched presence of T. forsythia and P. gingivalis in patients with
high RA activity seems to coincide with higher ammonium levels in
the saliva samples. This same effect is observed when comparing the
cultures the bacterial strains, where these two bacteria were the only
ones that showed an increase in ammonium generation. We would pri-
marily support the hypothesis that the increase in ammonium content in
our enzymatic assay is a consequence of the action of PAD proteins, an
event clearly demonstrated for P. gingivalis (Gabarrini et al., 2015,
Montgomery et al., 2016); however, it remains to be evaluated in the
case of T. forsythia. In any case, the results of this study suggest that
the high prevalence of T. forsythia significantly alters the oral microen-
vironment and that this change seems to be related to the increased
clinical activity in patients with RA. On the contrary, however, no asso-
ciation was found between total ammonium levels in saliva, bacteria
prevalence and αCCP antibody titres, suggesting that the autoantibody
repertoire induced by PD is more complex than expected or, as others
have previously described, that the autoantibody repertoire is predom-
inantly oriented to uncitrullinated peptides (De Pablo, P. et al. 2014).
Another important limitation of our study is the fact that the RA
patients had different durations of disease‐modifying antirheumatic
drug treatment, although no differences in treatment were evident
between disease activity groups (Table 1). Another limiting parameter
was the heterogeneous number of patients in the disease activity
groups, where 23% of all patients showed low activity when compared
to the high activity group (77%). With respect to PD, and per previous
studies, a high percentage of Mexican RA patients fall in the groupwith severe PD (>80%). Finally, oral samples evaluated in this study
were constituted by saliva, which could differ in protein and bacterial
content from the gingival crevicular fluid.
In conclusion, our present results confirm that high RA activity is
associated with severe PD, probing depth, high salivary total ammo-
nium levels, and the presence of T. forsythia in the oral microenviron-
ment, suggesting that other bacteria than P. gingivalis could be
involved in the development of RA. The search for more bacteria and
their association with RA are an important motive for improving care
in oral hygiene and the quality of life of patients.CONFLICT OF INTEREST
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grant (355015).CLINICAL RELEVANCE
Scientific rationale for study
The role of periodontal bacterial citrullination (mediated by
Porphyromonas gingivalis) is a risk factor for the development of auto-
antibodies in RA; however, this might not be an isolated event but part
of a larger interaction between bacterium and other risk factors leading
to autoimmunity.
Principal findings
Disease activity in RA patients is associated with the presence of
Tannerella forsythia and a higher ammonium levels in saliva, suggesting
that this microorganism acts synergically with other risk factors in RA
inflammation, including P. gingivalis.
Practical implications
P. gingivalis and T. forsythia act synergically in RA patients leading to
greater RA disease activity.
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